Dooley joins clinical pharmacology board
Dr. Dooley's three-year term on the board of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) begins in May.
Dr. Dooley's three-year term on the board of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) begins in May.
Nine faculty in four different divisions are among the 25 new faculty selected for membership in Vanderbilt University School of Medicine's Academy for Excellence in Education.
Eleven current Vanderbilt University faculty members are included in the 2024 list of “Highly Cited Researchers” around the world whose papers have been cited most frequently by other scientists.
Anna Person, MD, professor of Medicine in the Division of Infectious Diseases, is the recipient of the 2024 Clinical Teacher Award from the Infectious Diseases Society of America (IDSA).
Five Department of Medicine faculty are among the 17 leaders across VUMC honored for their expertise in clinical care, research, education and administration.
The clinic, led by Drs. Elizabeth Phillips and Cosby Stone, has seen groundbreaking discoveries in personalized care and diagnosis for allergy, especially delayed drug allergy, and has advanced discoveries in the optimal process to test patients for drug allergies.
Kelly Dooley, MD, PhD, MPH, Addison B. Scoville Jr. Professor of Medicine and director of the Division of Infectious Diseases, has received a MERIT Award (Method to Extend Research in Time Award) from the NIH's National Institute of Allergy and Infectious Diseases (NIAID). One of 15 MERIT awards that will be issued by the NIAID this year, this new grant serves to expand an ongoing international TB prevention trial to include pregnant women, children and people receiving certain drugs for HIV infection.
With a $3 million research grant, Henrique Serezani, PhD, Associate professor of Medicine in the Division of Infectious Diseases at Vanderbilt University Medical Center, will investigate how altered metabolism in diabetes affects inflammation and sepsis.
Sweeping data integration and clinical trial simulations are needed to help decide which targets to prioritize in researching new tuberculosis treatment regimens. Kelly Dooley, MD, PhD, MPH, the Addison B. Scoville, Jr. Professor of Medicine and director of the Division of Infectious Diseases and at Vanderbilt University Medical Center, is one of four co-principal investigators for the five-year multicenter project.
In late June, Jennifer Gaddy, PhD, associate professor of Medicine in the Division of Infectious Diseases, was named one of seven 2024 grant recipients of the Next Gen Pregnancy Initiative at the Burroughs Wellcome Fund and one of three 2024 Discovery Research Grant recipients by the March of Dimes.